Adverse Recalls in Canada

IXCHIQ (chikungunya vaccine, live, attenuated) and the Risk of Serious Adverse Reactions in Medically Frail Individuals 65 Years of Age and Older

New safety information - Product safety - Adverse reaction

View recall details →

Ezetrol (ezetimibe) and the Risks of Drug-Induced Liver Injury and Severe Cutaneous Adverse Reactions

Product safety

View recall details →

Paqui brand 2023 One Chip Challenge recalled due to reported adverse reactions

Other

View recall details →

Janus Kinase Inhibitors and the Risk of Major Adverse Cardiovascular Events, Thrombosis (Including Fatal Events) and Malignancy

New safety information - Product safety

View recall details →

PAXLOVID (nirmatrelvir and ritonavir) - Dosing and Dispensing in Renal Impairment, Risk of Serious Adverse Reactions Due to Drug Interactions, and English-Only Labels

Labelling - New safety information - Supply - COVID

View recall details →

XELJANZ/XELJANZ XR (tofacitinib) – Risk of Major Adverse Cardiovascular Events, Malignancy, Thrombosis and Infection

New safety information - Product safety

View recall details →

Medtronic Heartware Ventricular Assist Device System - Recall Due to Risk of Neurological Adverse Events, Mortality and Delay or Failure to Restart

Medical devices - Product safety

View recall details →

Adverse events in Europe following immunization with the AstraZeneca COVID-19 vaccine

COVID

View recall details →

COVID-19 Vaccine Moderna: Updated English-only Global Vial and Carton Labels and Post-Market Adverse Reaction Information

Product safety

View recall details →

Pfizer-BioNTech COVID-19 Vaccine: Updated Dosage and Administration and Post-Market Adverse Reaction Information

COVID - Product safety

View recall details →